Table 3.
aOR (95%CI) |
p value | |
---|---|---|
Outcome - weaning success | ||
RF-CSA ≥ 1.80cm2 (reference: yes)* | 5.85 (1.22 - 28) | 0.027 |
DEx ≥ 1.25cm (reference: yes)* | 2.11 (0.52 - 8.54) | 0.295 |
MIP† | 1.06 (1.01 - 1.11) | 0.015 |
SOFA† | 0.67 (0.5-0.9) | 0.008 |
SAPS III† | 0.96 (0.91 - 1.02) | 0.162 |
Active infection * (reference: yes) | 0.07 (0 - 1.14) | 0.062 |
Outcome - weaning success | ||
RF-CSA ≥ 1.80cm2 plus DEx ≥ 1.25cm (reference: yes)* | 20.81 (2.38 - 182.28) | 0.006 |
MIP† | 1.07 (1.01 - 1.12) | 0.011 |
SOFA† | 0.63 (0.46 - 0.86) | 0.003 |
SAPS III† | 0.95 (0.9 - 1.02) | 0.139 |
Days on MV pre weaning (≤ 21 days)* | 3.66 (0.62 - 21.49) | 0.151 |
Active infection* | 0.08 (0 - 1.51) | 0.091 |
Outcome - ICU mortality | ||
RF-CSA ≥ 1.80cm2 (reference: yes)* | 0.32 (0.08 - 1.26) | 0.096 |
DEx ≥ 1.25cm (reference: yes)* | 1.35 (0.31 - 5.76) | 0.687 |
MIP† | 0.95 (0.9 - 0.99) | 0.005 |
SOFA† | 1.78 (1.3 - 2.44) | <0.001 |
SAPS III† | 1.04 (0.98 - 1.1) | 0.142 |
Outcome - ICU mortality | ||
RF-CSA ≥ 1.80cm2 plus DEx ≥ 1.25cm (reference: yes)* | 0.19 (0.03 - 1.08) | 0.061 |
MIP† | 0.94 (0.9 - 0.99) | 0.014 |
SOFA† | 1.05 (0.99 - 1.11) | 0.104 |
Days on MV pre weaning (< 21 days)* | 0.28 (0.05 - 1.51) | 0.139 |
Outcome - palliative care | ||
RF-CSA ≥ 1.80cm2 (reference: yes)* | 0.59 (0.16 - 2.14) | 0.427 |
DEx ≥ 1.25cm (reference: yes)* | 0.18 (0.04 - 0.76) | 0.019 |
MIP† | 0.98 (0.95 - 1.01) | 0.185 |
SOFA† | 1.38 (1.08 - 1.76) | 0.01 |
SAPS III† | 1.07 (1.01 - 1.13) | 0.019 |
Outcome - palliative care | ||
RF-CSA ≥ 1.80cm2 plus DEx ≥ 1.25cm (reference: yes)* | 0.2 (0.05 - 0.84) | 0.027 |
SOFA† | 1.26 (1.05 - 1.51) | 0.015 |
SAPS III† | 1.06 (1.01 - 1.11) | 0.013 |
aOR - adjusted odds ratio; 95%CI - 95% confidence interval; RF-CSA - rectus femoris cross-sectional area; DEx - diaphragmatic excursion; MIP - maximal inspiratory pressure; SOFA - Sequential Organ Failure Assessment; SAPS III - Simplified Acute Physiology Score III; ICU - intensive care unit; MV - mechanical ventilation.
Categorical variables in the model; † continuous variables in the model.